Literature DB >> 9781475

Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study.

S Madhusoodanan1, R Brenner, D Moise, J Sindagi, I Brafman.   

Abstract

The authors describe an atypical presentation of Huntington's disease in a 55-year-old woman who manifested essentially psychotic and cognitive symptoms. A positive family history of Huntington's disease and DNA analysis helped to establish the diagnosis. The patient's psychotic symptoms improved with risperidone. The psychiatric and cognitive symptoms of Huntington's disease are reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781475     DOI: 10.1023/a:1022302305262

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  5 in total

1.  Psychosis with Huntington's disease: role of antipsychotic medications.

Authors:  Jonathan Ding; Amin Muhammad Gadit
Journal:  BMJ Case Rep       Date:  2014-08-19

2.  Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Margaret E O'Rourke; Peg Nopoulos; Henry L Paulson; Jane S Paulsen
Journal:  Ann Clin Psychiatry       Date:  2008 Jan-Mar       Impact factor: 1.567

3.  Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care.

Authors:  Raphael J. Leo; Paula Del Regno
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-12

Review 4.  Symptomatic treatment of Huntington disease.

Authors:  Octavian R Adam; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  International Guidelines for the Treatment of Huntington's Disease.

Authors:  Anne-Catherine Bachoud-Lévi; Joaquim Ferreira; Renaud Massart; Katia Youssov; Anne Rosser; Monica Busse; David Craufurd; Ralf Reilmann; Giuseppe De Michele; Daniela Rae; Ferdinando Squitieri; Klaus Seppi; Charles Perrine; Clarisse Scherer-Gagou; Olivier Audrey; Christophe Verny; Jean-Marc Burgunder
Journal:  Front Neurol       Date:  2019-07-03       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.